Leadership & Pay ·
Gain Therapeutics names CEO Gene Mack interim CFO after Gianluca Fuggetta resigns as SVP of Finance
GANXGain Therapeutics, Inc.
Gain Therapeutics, Inc. announced the resignation of Gianluca Fuggetta as Senior Vice President of Finance and principal financial officer, effective September 30, 2026, to pursue other opportunities. The Board appointed current President and CEO Gene Mack as interim Chief Financial Officer, assuming duties as principal financial and accounting officer starting October 1, 2026, while continuing in his existing roles. Mr. Mack’s compensation remains unchanged, and the company is actively searching for a permanent replacement. Gain Therapeutics operates in the biotechnology industry, focusing on drug discovery.